Herbas VPB

Print
EN | LT
LT - USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION
EN - USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/415 (2006.01)
A61K 45/06 (2013.01)
A61K 31/4174 (2006.01)
A61K 31/4174 (2013.01)
A61K 45/06 (2006.01)
A61K 47/10 (2013.01)
A61K 47/10 (2017.01)
A61K 9/006 (2013.01)
A61P 25/00 (2006.01)
A61K 9/2027 (2013.01)
A61K 9/20 (2006.01)
A61P 25/00 (2018.01)
A61K 9/00 (2006.01)
European patent
(11) Number of the document 3562486
(13) Kind of document T
(96) European patent application number 17885750.4
Date of filing the European patent application 2017-12-29
(97) Date of publication of the European application 2019-11-06
(45) Date of publication and mention of the grant of the patent 2024-03-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/069030
Date 2017-12-29
PCT application publication
(87) Number WO 2018/126182
Date 2018-07-05
Priority applications
(30) Number Date Country code
201662441164 P 2016-12-31 US
201762471393 P 2017-03-15 US
201762542323 P 2017-08-08 US
Inventors
(72)
NANDABALAN, Krishnan , US
YOCCA, Frank , US
SHARMA, Sameer , US
Grantee
(73) BioXcel Therapeutics, Inc. , 555 Long Wharf Drive, 5th Floor, New Haven, CT 06511, US
Title
(54) USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION
  USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION